Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia

PHASE3CompletedINTERVENTIONAL

Enrollment

143

Participants

Timeline

Start Date

November 5, 2014

Primary Completion Date

September 5, 2015

Study Completion Date

October 12, 2015

Conditions

Functional Dyspepsia

Interventions

DRUG

UI05MSP015CT

UI05MSP015CT and Placebo of Gasmotin

DRUG

Gasmotin

Placebo of UI05MSP015CT and Gasmotin

All Listed Sponsors

lead

Korea United Pharm. Inc.

INDUSTRY

NCT03225248 - Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia | Biotech Hunter | Biotech Hunter